Clal Insurance Enterprises Holdings Ltd - EVOGENE LTD ownership

EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 49 filers reported holding EVOGENE LTD in Q1 2021. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Clal Insurance Enterprises Holdings Ltd ownership history of EVOGENE LTD
ValueSharesWeighting
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q2 2020$591,000
-15.3%
591,2640.0%0.01%
-29.4%
Q1 2020$698,000
-99.9%
591,264
+65669.1%
0.02%
-97.3%
Q4 2019$591,264,000
+63204.5%
899
-99.8%
0.63%
+2656.5%
Q3 2019$934,000
-1.9%
591,2640.0%0.02%
+4.5%
Q2 2019$952,000
-12.0%
591,2640.0%0.02%
-18.5%
Q1 2019$1,082,000
-8.9%
591,264
-1.5%
0.03%
-12.9%
Q4 2018$1,188,000
-36.3%
599,9810.0%0.03%
-38.0%
Q3 2018$1,866,000
+8.7%
599,9810.0%0.05%
+11.1%
Q2 2018$1,716,000
-9.9%
599,9810.0%0.04%
-11.8%
Q1 2018$1,905,000
+3.4%
599,9810.0%0.05%
+4.1%
Q4 2017$1,842,000
-30.9%
599,9810.0%0.05%
-23.4%
Q3 2017$2,664,000
-12.3%
599,9810.0%0.06%
+6.7%
Q2 2017$3,036,000
-5.4%
599,9810.0%0.06%
-7.7%
Q1 2017$3,208,000
+4.8%
599,9810.0%0.06%
+14.0%
Q4 2016$3,060,000
-20.1%
599,9810.0%0.06%
-33.7%
Q3 2016$3,828,000
+2.2%
599,9810.0%0.09%
-9.5%
Q2 2016$3,744,000
-4.1%
599,9810.0%0.10%
-16.7%
Q1 2016$3,906,000
-19.1%
599,981
-0.0%
0.11%
-11.6%
Q4 2015$4,830,000
-2.4%
600,0000.0%0.13%0.0%
Q3 2015$4,950,000
-6.7%
600,0000.0%0.13%
+5.7%
Q2 2015$5,304,000
+0.2%
600,0000.0%0.12%0.0%
Q1 2015$5,292,000
-4.2%
600,0000.0%0.12%
-7.6%
Q4 2014$5,526,000600,0000.13%
Other shareholders
EVOGENE LTD shareholders Q1 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 293,057$481,0000.20%
Eidelman Virant Capital 113,000$185,0000.07%
Susquehanna International Group Ltd. 31,753$55,0000.02%
ARK Investment Management 3,611,842$6,020,0000.02%
Senvest Management, LLC 230,606$378,0000.01%
Csenge Advisory Group 28,700$96,0000.01%
MGO ONE SEVEN LLC 25,340$42,0000.00%
OCCUDO QUANTITATIVE STRATEGIES LP 25,826$42,0000.00%
SNS Financial Group, LLC 10,000$16,0000.00%
Vident Investment Advisory, LLC 49,786$82,0000.00%
View complete list of EVOGENE LTD shareholders